Chapter 29

Eicosanoids and Algesia in Inflammation

Lynne Murray

Lynne Murray

Imperial College School of Medicine, SAF Building, Exhibition Road, Leukocyte Biology, BMS Division, South Kensington, London SW7 2AZ, UK

Search for more papers by this author
Henry Sarau

Henry Sarau

Respiratory and Inflammation, Centre for Excellence in Drug Discovery, GlaxoSmithKline, UW2532, 709 Swedeland Road, King of Prussia, PA 19406, USA

Search for more papers by this author
Kristen E. Belmonte

Kristen E. Belmonte

Respiratory and Inflammation, Centre for Excellence in Drug Discovery, GlaxoSmithKline, UW2532, 709 Swedeland Road, King of Prussia, PA 19406, USA

Search for more papers by this author
First published: 23 March 2004
Citations: 2

Summary

This chapter contains sections titled:

  • Nociception: Physiological Process

  • Transmission of the Nociceptive Stimulus

  • Nociceptors

  • Chemical Mediators Involved in Nociception

  • Expression and Localization of Prostaglandins, Prostaglandin Receptors and Cyclooxygenases Implicate Prostanoids in Nociception

  • The Role of Prostaglandins in Inflammatory Pain

  • Induction of COX-2 and Increased Prostaglandin Synthesis During Inflammation

  • Role of Prostaglandins in Sensitizing Nerve Endings and Peripheral Nerve Fibres

  • Prostaglandins Involved in the Maintenance of Pain

  • References

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.